A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Sarah M. Bhagat.

Business address: C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA, 02210

Get insider transactions for this reporting owner

Sarah M. Bhagat has filed 6 SEC EDGAR filings since 23 Jul 2020

Recent SEC filings for Sarah M. Bhagat including 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	4	20 Jun 2024	18 Jun 2024	001-39397
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	15 Jun 2023	13 Jun 2023	001-39397
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	14 Jun 2022	10 Jun 2022	001-39397
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	25 Jun 2021	23 Jun 2021	001-39397
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	24 Jul 2020	23 Jul 2020	001-39397
3	Open 3 document	View SEC filing for 3	FORM 3 SUBMISSION	23 Jul 2020	23 Jul 2020	001-39397

Sarah M. Bhagat files with the SEC under CIK 0001817762. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.